Introduction:
The Male Breast Cancer (MBC) is an uncommon cancer accounting for 1% of all malignancies in men and around 1% of all cases of of breast Cancer 1 . Rudimentary nature of breast in males and its proximity to skin makes all of them present as advanced cancer (T4 a&b). There is no standard protocol for screening for male breast cancer. The mean age of diagnosis for men with breast cancer is 67 years which is approximately 5-10 years older than in women The incidence is increased over the past 25 years and various risk factors have been identified. Though there are no established treatment protocols for MBC they are treated like female breast cancer with subtle differences .Because of lack of awareness and nosreening methods and poor socio economic status most of these patients present in advanced stage resulting in poor survival rates inspite of offering multimodality treatment. All our 10 patients came in advanced stage being partially treated elsewhere in one case.
Materials and Methods:
3686 Cancer patients attended our hospital in 2014 and 2015(table-I). Breast cancer accounts for 14% % of total cancers second only to cancer Cervix. There were ten male Breast cancer patients accounting for 2% of Breast cancer patients and 0.27% of all cancers. The youngest patient's is 54 yrs old and oldest is 76 yrs. The mean age of the patient is 63 yrs ( Table-II ). All patients had unilateral only, right side two and left side eight (Table-III) similar to female breast cancer.unlike in other series where right side was more common 4 Eight patients came to us without evaluation. seven are clinically Stage III and one stage IV. Trucut biopsy was done for all patients to confirm the diagnosis. X-Ray chest was done to detect lung metastasis. If no metastasis in chest X-Ray then CT chest done. Bone scan is done to detect Bone metastasis. . All patients presented with advanced disease (stage III-8 & stage IV-2). One patient of stage III was referred to us after surgery (modified Radical Mastectomy). He received adjuvant chemo therapy and Radiation. One patient of stage III treated outside with modified radical mastectomy and chemotherapy presented with multiple bone and liver metastasis and treated with palliative therapy. All patients were discussed in Multidisciplinary Tumour board .which consists of medical, surgical, and radiation oncologists Though surgery was planned for one patient it could not be performed for some technical reasons and hence referred to another institution but he lost for follow up.. Seven patients were started on neo adjuvant chemotherapy. Only one patient completed chemotherapy, underwent modified radical mastectomy received adjuvant Radiation and chemotherapy and alive till today ( figure 1& 2) 
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. Six patients discontinued neo adjuvant chemotherapy after few cycles of chemotherapy. One patient presented with multiple bone and liver metastasis and palliative treatment was provided.
One patient treated outside with surgery chemotherapy and Radiation, presented to us with distant metastasis, multiple bone and liver metastasis. He was advised immuno histochemistry study to start systemic hormone therapy. He defaulted ( Table-V) .
Results:
Three patients of locally advanced disease are alive. Two of them have completed the treatment and on follow-up. One patient who discontinued treatment is also alive with disease. Four patients died could be due to malignancy. Two patients are lost for follow up though we have Hospital based cancer Registry under ICMR and data is collected periodically. All our patients are illiterate and from poor socioeconomic status. and hence could not come for regular follow up. 
Discussion
The incidence of cancer is increasing in our country due to increasing life expectancy and life style changes. The breast cancer incidence is increasing in both male and female sex in our country. In both sexes the cancer presents present in advanced stage in our country. There has been a decrease in the incidence of breast cancer in developed countries due to decrease in the use of hormone replacement therapy. Highest incidence of breast cancer was found to be in the age group of 41-50 in our hospital. Klinefilter's syndrome, exogenous estrogen, obesity, and a history of prostate cancer are all associated with hormonal imbalance. Also prior exposure to radiation or electromagnetic fields and occupational exposure to aromatic hydrocarbons contribute to the risk.5Apart from these a family history of breast carcinoma,clinical conditions causing hypoandrogenism,testicular trauma or infertility,liver disease causing hyper estrogenism and gynaecomastia have all been implicated as possible risk factors 3 Klinefelter's syndrome (XXY,XXXY) is associated with high oestrogen and low levels of Androgens and leads to Gynaecomastia and male breast cancer. Men who inherit abnormal mutations in BRCA I and BRCA II are at high risk of breast Cancer.
The diagnostic evaluation and staging system used for MBC are the same as for female breast cancer.Only 48%of MBC are diagnosed stage 1 or stage 2 so that in comparision with women men tend to be diagnosed late1.All our patients werein stage 3 or 4.
The male breast cancer is managed almost similar to female breast cancer. The paucity of male breast cancer patients precludes randomised controlled trials.
Thorough clinical examination has to be done. Unlike female Breast cancer, x-ray imaging of the ipsi lateral and contra lateral breast may not be feasible. In obese patients Ultra sonogram and MRI can be used to evaluate the Breast. Since most of the patients present with advanced stage, CT scan chest and bone scan to be done to rule out distant metastasis. PET scan is emerging as an alternative for metastatic evaluation.
Fine needle aspiration cytology can confirm the diagnosis. When neoadjuvant chemotherapy is planned tru cut biopsy to be done for immune histochemistry to know Estrogen and Progestrone receptor status and HER-2(Human epidermal growth factor receptor-2) status.
In operable breast cancer, surgery is done as an initial modality. Breast conservation surgery is not done usually. Modified Radical Mastectomy is done. Sentinel node dissection not done.
Complete axillary dissection from level I to level lll done. Some amount of Pectoralis Major Muscle is also taken when the tumour is tethered to the muscle. When upfront surgery is not possible neoadjuvant chemotherapy is given and surgery done later. Sometimes primary closure may not be possible and reconstruction may be needed . Latissimus dorsi and transverse rectus abdominis muscles are used for reconstruction.
Adriamycin and paclitaxel based four cycles are given as neoadjuvant chemotherapy. Response to chemotherapy is assessed after two cycles. Adjuvant chemotherapy is also given after Surgery. Herceptin is given in patients for whom HER-2 is overexpressed. All patients should receive Radiation. Fifty Grey in twenty five fractions given. The chest wall, supra and infra clavicular fossa are irradiated. Tamoxifen and aromatese inhibitors are given in ER & PR positive patients.
Metastatic disease is treated by systemic therapy. Mono chemotherapy is given. Targeted therapy with lapatinib is also given in select patients. Palliative mastectomy is done for fungating and bleeding tumours. Occasionally metastatectomy is done. Radiation is given for brain and bone metastasis. Bisphosphonates are used for treatment of hypercalcemia. 6,7
Conclusion
Male and female breast cancer patients usually present with advanced stage and high morbidity and mortality in our country. The high mortality in male breast cancer can be reduced by detecting the cancer at an early stage. Awareness about both male and female breast cancer is to be created among physician and public. High risk men to be periodically screened by physician. Multicenter prospective randomised trials are required to validate the etiological factors and optimal management stratagies and for early diagnosis and improved survival.
